Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -202.06% | 70.82% | 20.19% | -23.03% | -4.40% |
| Total Depreciation and Amortization | -3.05% | -22.96% | -1.22% | -1.09% | -1.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.95% | -183.28% | 317.60% | -0.89% | 29.98% |
| Change in Net Operating Assets | -324.20% | 551.35% | -96.43% | 860.07% | 60.40% |
| Cash from Operations | -90.47% | -8.81% | 27.22% | 27.74% | 6.95% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 7,627.94% | -74.53% | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 4,516.67% | -102.52% | 215.22% |
| Cash from Financing | 8,299.15% | -101.07% | 8,803.23% | -87.73% | 344.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.89% | -279.71% | 144.68% | 23.88% | 15.33% |